메뉴 건너뛰기




Volumn 45, Issue 11, 2010, Pages 1658-1660

Second allo-SCT from a different donor can improve severe steroid-resistant gut GVHD

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BUSULFAN; CYCLOPHOSPHAMIDE; DACLIZUMAB; FLUDARABINE; INFLIXIMAB; LENALIDOMIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANOBINOSTAT; RITUXIMAB; TACROLIMUS;

EID: 78149468993     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2010.17     Document Type: Letter
Times cited : (6)

References (10)
  • 1
    • 65549107728 scopus 로고    scopus 로고
    • Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: Retrospective analysis of a multicenter phase III study
    • Carnevale-Schianca F, Leisenring W, Martin PJ, Furlong T, Schoch G, Anasetti C et al. Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study. Biol Blood Marrow Transplant 2009; 15: 749-756.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 749-756
    • Carnevale-Schianca, F.1    Leisenring, W.2    Martin, P.J.3    Furlong, T.4    Schoch, G.5    Anasetti, C.6
  • 2
    • 44449103854 scopus 로고    scopus 로고
    • Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: A comparison of myeloablative and nonmyeloablative conditioning regimens
    • DOI 10.1038/sj.bmt.1705987, PII 1705987
    • Sala-Torra O, Martin PJ, Storer B, Traina F, Sorror ML, Storb R et al. Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison ofmyeloablative and nonmyeloablative conditioning regimens. Bone Marrow Transplant 2008; 41: 887-893. (Pubitemid 351761691)
    • (2008) Bone Marrow Transplantation , vol.41 , Issue.10 , pp. 887-893
    • Sala-Torra, O.1    Martin, P.J.2    Storer, B.3    Traina, F.4    Sorror, M.L.5    Storb, R.6    Sandmaier, B.M.7    Flowers, M.E.D.8
  • 4
    • 67651230892 scopus 로고    scopus 로고
    • Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease
    • Rao K, Rao A, Karlsson H, Jagani M, Veys P, Amrolia PJ. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease. J Pediatr Hematol Oncol 2009; 31: 456-461.
    • (2009) J Pediatr Hematol Oncol , vol.31 , pp. 456-461
    • Rao, K.1    Rao, A.2    Karlsson, H.3    Jagani, M.4    Veys, P.5    Amrolia, P.J.6
  • 6
    • 78149464995 scopus 로고    scopus 로고
    • Prognostic factors and outcomes of severe gastrointestinal graft versus host disease (GI GVHD) after allogeneic hematopoietic stem cell transplantation
    • abstract 336
    • Castilla-LLorente C, Nash RA, McDonald GB, Storer BE, Martin PJ. Prognostic factors and outcomes of severe gastrointestinal graft versus host disease (GI GVHD) after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009; 15(Suppl 2); S120 (abstract 336).
    • (2009) Biol Blood Marrow Transplant , vol.15 , Issue.SUPPL. 2
    • Castilla-Llorente, C.1    Nash, R.A.2    McDonald, G.B.3    Storer, B.E.4    Martin, P.J.5
  • 7
    • 49349086756 scopus 로고    scopus 로고
    • Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor
    • Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K et al. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor. Exp Hematol 2008; 36: 1216-1225.
    • (2008) Exp Hematol , vol.36 , pp. 1216-1225
    • Taniguchi, Y.1    Yoshihara, S.2    Hoshida, Y.3    Inoue, T.4    Fujioka, T.5    Ikegame, K.6
  • 8
    • 0141702025 scopus 로고    scopus 로고
    • Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor
    • DOI 10.1038/sj.bmt.1704170
    • Wiesmann A, Bader P, Bamberg M, Faul C, Kanz L, Einsele H. Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor. Bone Marrow Transplant 2003; 32: 511-513. (Pubitemid 37160967)
    • (2003) Bone Marrow Transplantation , vol.32 , Issue.5 , pp. 511-513
    • Wiesmann, A.1    Bader, P.2    Bamberg, M.3    Faul, C.4    Kanz, L.5    Einsele, H.6
  • 9
    • 13944262008 scopus 로고    scopus 로고
    • Second allografts for relapsed hematologic malignancies: Feasibility of using a different donor
    • DOI 10.1038/sj.bmt.1704761
    • Duus JE, Stiff PJ, Choi J, Parthasarathy M, Rodriguez T, Toor AA. Second allografts for relapsed hematologic malig-nancies: feasibility of using a different donor. Bone Marrow Transplant 2005; 35: 261-264. (Pubitemid 40268297)
    • (2005) Bone Marrow Transplantation , vol.35 , Issue.3 , pp. 261-264
    • Duus, J.E.1    Stiff, P.J.2    Choi, J.3    Parthasarathy, M.4    Rodriguez, T.5    Toor, A.A.6
  • 10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.